In Texas, ex-vegan restaurateurs put MAHA’s vision for farming to the test

Health secretary Robert F. Kennedy Jr. envisions a back-to-the-land movement based on "regenerative agriculture," but it isn't an easy go.

October 16, 2025 Check out STAT+

Sponsored By

Brenda Bazán for STAT STAT+ | In Texas, ex-vegan restaurateurs put MAHA's vision for farming to the test A former vegan chef is trying to execute MAHA's dream of a utopian future based on small-scale, family-owned farms. By Isabella Cueto Former NIH leaders lament 'constant chaos' at the agency, and caution it's not over Former NIH leaders say the worst may be yet to come at NIH, where this year has been "like living in a washing machine." By O. Rose Broderick STAT+ | Biotech leaders say uncertainty at FDA threatens drug development After losing key staff and leadership, FDA rejections of Replimune and Capricor therapies show how instability threatens biotech innovation – and patients. By Lizzy Lawrence La Jolla Institute for Immunology This scientist is revealing the immune system in our nasal passages The La Jolla Institute for Immunology researcher has helped lead the way in understanding a critical part of the immune system: the upper airway. By Allessandra DiCorato STAT+ | After hiring of a former top FDA official, Eli Lilly's chief scientific officer isn't fazed by revolving doors "What kind of society would we live in if government jobs were a one-way door?" asked Eli Lilly's chief scientific officer, Dan Skovronsky. By Ed Silverman AMA president deflects criticism of organization's restrained approach to the Trump administration Bobby Mukkamala highlighted the alignment between federal health officials and the AMA on issues like prior authorization at the STAT Summit By Theresa Gaffney Jeff Pinette for STAT Baby KJ's doctors will ask FDA this winter to OK a clinical trial of pioneering gene editing approach A bouncing Baby KJ, resplendent in a toddler tuxedo, wows crowd at STAT Summit as experts discuss scaling up personalized medicine By Megan Molteni Veteran biotech executive Clive Meanwell on drug pricing and the obesity market Meanwell chatted about the evolving obesity drug market, and the continued need for drugs to treat diseases with large prevalence. By Adam Feuerstein, Allison DeAngelis, and Elaine Chen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser